12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·2 days ago, 04:06 PMHOWL+102.57%RYOJ+4.67%
EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercializationQuartr·2 days ago, 03:16 PMEXOZ+1.56%
EXOZYMES INC. 2Q 2026: Revenue $0 Net loss $(5.25M) — 10-Q SummaryTradingView·Aug 13 at 02:51 PMEXOZ+1.56%
Exozymes FY26 Q2 net loss widens 22% to $2.88 million; revenue remains no revenuePUBT·Aug 13 at 02:50 PMEXOZ+1.56%
eXoZymes Raises $0.64 Million Via Unit Offering; Adds MDB Placement Pact and Warrant CoverageTradingView·Jul 1 at 03:33 PMEXOZ+1.56%
Exozymes prices registered direct offering at USD 18 per unit, raising USD 639,990 grossPUBT·Jul 1 at 03:32 PMEXOZ+1.56%
eXoZymes wins USD 2.03 million NIH grant for cannabinoid analog developmentPUBT·Jun 26 at 05:03 AMEXOZ+1.56%
Exozymes wins NIH grant worth $2.03 million for cannabinoid analog developmentPUBT·Jun 24 at 03:10 PMEXOZ+1.56%
Exozymes Raises $5.95 Million in Underwritten Equity Offering Led by MDB CapitalTradingView·Jun 17 at 04:13 PMEXOZ+1.56%
eXoZymes Inc. Announces Closing of $6 Million Public OfferingMorningStar·Jun 17 at 03:23 PMEXOZ+1.56%
eXoZymes closes USD 5.95 million follow-on offering of stock and warrantsPUBT·Jun 17 at 03:10 PMEXOZ+1.56%
